Sodium-Glucose Cotransporter-2 Inhibitors: Heart Failure and Renal Protection Indications

被引：2
|
作者：
El Hussein, Mohamed Toufic [1 ,2 ,3 ]
Bell, Nicole [4 ]
机构：
[1] Mt Royal Univ Calgary, Fac Hlth Community & Educ, Sch Nursing & Midwifery, Calgary, AB, Canada
[2] Univ Calgary Calgary, Fac Nursing, Calgary, AB, Canada
[3] Rockyview Gen Hosp Calgary, Coronary Care Unit, Med Cardiol, Calgary, AB, Canada
[4] Mt Royal Univ, Calgary, AB, Canada
来源：
JNP- THE JOURNAL FOR NURSE PRACTITIONERS | 2022年 / 18卷 / 02期
关键词：
heart failure; renal failure; sodium-glucose cotransporter-2 inhibitors; type; 2; diabetes; CARDIOVASCULAR EVENTS; EMPAGLIFLOZIN; RATIONALE; DESIGN; RISK;
D O I：
10.1016/j.nurpra.2021.09.002
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) are a class of oral antihyperglycemic drugs recently added to clinical practice guidelines to manage type 2 diabetes mellitus (T2DM). Recent clinical trials have established significant benefits in using SGLT-2is to treat both heart failure and renal disease. This article aims to explain the clinical benefits of inhibiting sodium-glucose cotransporter-2 proteins in patients with T2DM, renal disease, and heart failure. These authors also seek to guide nurse practitioners in prescribing SGLT-2is. Evidence-based guidance for nurse practitioners to treat T2DM, heart failure, and renal disease is likely to improve patients' clinical outcomes and decrease associated morbidities. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：179 / 184
页数：6
相关论文
共 50 条
  • [41] Sodium-glucose cotransporter-2 inhibitors in heart failure patients: an appraisal of recent cardiovascular outcome trials
    Kocyigit, Duygu
    Kocyigit, Alime S.
    Hussain, Muzna
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (06): : 629 - 651
  • [42] Sodium-glucose cotransporter-2 inhibitors in heart failure: Potential decongestive mechanisms and current clinical studies
    Biegus, Jan
    Fudim, Marat
    Salah, Husam M. M.
    Heerspink, Hiddo J. L.
    Voors, Adriaan A. A.
    Ponikowski, Piotr
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (09) : 1526 - 1536
  • [43] Role of Sodium-Glucose Cotransporter-2 Inhibition in the Treatment of Adults With Heart Failure
    Sharma, Abhinav
    Ezekowitz, Justin A.
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 103 - 110
  • [44] Effects of sodium-glucose cotransporter-2 inhibitors on nutritional status in heart failure with reduced ejection fraction
    Arslan, Kadem
    Yilmaz, Emre
    Aydin, Ercan
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (11): : 1576 - 1581
  • [45] A Sweet Solution for Heart Failure With Preserved Ejection Fraction: The Role of Sodium-Glucose Cotransporter-2 Inhibitors
    Salazar, Ruben A.
    Stroud, Steven C.
    DeFilippis, Ersilia M.
    CIRCULATION-HEART FAILURE, 2023, 16 (02) : 229 - 231
  • [46] The Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Improving Morbidity and Mortality of Heart Failure: A Systematic Review
    Thiagaraj, Suvedha
    Shukla, Twisha S.
    Gutlapalli, Sai Dheeraj
    Farhat, Hadi
    Irfan, Huma
    Muthiah, Kanmani
    Pallipamu, Namratha
    Taheri, Sogand
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [47] Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure A Systematic Review and Meta-analysis
    Zou, Xinyu
    Shi, Qingyang
    Vandvik, Per Olav
    Guyatt, Gordon
    Lang, Chim C.
    Parpia, Sameer
    Wang, Si
    Agarwal, Arnav
    Zhou, Yiling
    Zhu, Ye
    Tian, Haoming
    Zhu, Zhiming
    Li, Sheyu
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 851 - +
  • [48] Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
    Kurczynski, Dominik
    Hudzik, Bartosz
    Jagosz, Marta
    Zabierowski, Jan
    Nowak, Jolanta
    Tomasik, Andrzej
    Badzinski, Arkadiusz
    Rozentryt, Piotr
    Gasior, Mariusz
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2022, 9 (07)
  • [49] Sodium-Glucose Cotransporter-2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
    Porcari, Aldostefano
    Cappelli, Francesco
    Nitsche, Christian
    Tomasoni, Daniela
    Sinigiani, Giulio
    Longhi, Simone
    Bordignon, Luca
    Masri, Ahmad
    Serenelli, Matteo
    Urey, Marcus A.
    Musumeci, Beatrice
    Cipriani, Alberto
    Canepa, Marco
    Eslam, Roza Badr
    Kronberger, Christina
    Chimenti, Cristina
    Zampieri, Mattia
    Allegro, Valentina
    Razvi, Yousuf
    Patel, Rishi
    Ioannou, Adam
    Rauf, Muhammad U.
    Petrie, Aviva
    Whelan, Carol
    Emdin, Michele
    Metra, Marco
    Merlo, Marco
    Sinagra, Gianfranco
    Hawkins, Philip
    Solomon, Scott
    Gillmore, Julian
    Fontana, Marianna
    CIRCULATION, 2023, 148 (25) : E303 - E303
  • [50] Sodium-glucose cotransporter-2 inhibitors reduce risk of nephrolithiasis
    Di Lellis, Maddalena Angela
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 674 - 675
12345